Related Experiment Video
Updated: Jul 12, 2026

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube
Published on: April 28, 2020
Evaluating patients with mildly elevated transaminase levels
Kimberly A Burns1, Shiney Kurian, Catherine C Burke
1Laura Lee Blanton Gynecologic Oncology Center, University of Texas M.D. Anderson Cancer Center, Houston, USA.
This case study details a 52-year-old woman with recurrent stage IV ovarian cancer. Despite initial successful treatment, she experienced rapid disease recurrence, highlighting challenges in managing advanced ovarian cancer.
Area of Science:
- Gynecologic Oncology
- Medical Oncology
Background:
- Advanced ovarian cancer presents significant treatment challenges.
- Recurrence is common even after initial response to therapy.
Observation:
- A 52-year-old woman with stage IV ovarian cancer underwent surgery and chemotherapy (paclitaxel and carboplatin).
- Initial treatment led to normalized tumor markers and no evidence of disease on imaging.
Findings:
- Disease recurred rapidly within three months post-treatment.
- Elevated CA-125 and a palpable vaginal apex mass confirmed recurrence.
Implications:
- This case underscores the aggressive nature of poorly differentiated papillary serous ovarian cancer.
- It highlights the need for vigilant monitoring and potentially novel therapeutic strategies for recurrent ovarian cancer.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Kidney Transplant III: Nursing Management
Serum Studies: Renal Function Tests
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

